Multiple Myeloma Treatment: A Long-Term, Stage-Based Journey
Featured

Multiple Myeloma Treatment: A Long-Term, Stage-Based Journey

Clinic Moves

FDA approves first new drug for rare blood cancer
Clinic Moves
October 13, 2026

FDA approves first new drug for rare blood cancer

The FDA approves ropeginterferon alfa-2b-njft for essential thrombocythemia, the first new treatment for the rare...

Gynecologic Oncologist Shares Lessons After Breast Cancer Diagnosis
Clinic Moves
October 7, 2026

Gynecologic Oncologist Shares Lessons After Breast Cancer Diagnosis

Breast cancer diagnosis taught Dr. Molly Greenwade, an oncologist, lessons on early detection while juggling...

Moderate Sleep Linked to Slower Biological Aging
Clinic Moves
October 1, 2026

Moderate Sleep Linked to Slower Biological Aging

A study in Nature overturns the assumption that longer sleep is universally better for aging....

Drug Approvals

Read our latest Drug Approvals articles.

Most breast bruises not linked to cancer
Drug Approvals October 14, 2026

Most breast bruises not linked to cancer

Most breast bruises are not linked to breast cancer unless they persist beyond two weeks,...

Doctors reject federal vaccine changes lacking scientific backing
Drug Approvals September 19, 2026

Doctors reject federal vaccine changes lacking scientific backing

Doctors reject federal vaccine changes lacking scientific backing as top medical groups like AAP and...

Outbreak Watch

Trial Briefs

All Posts

Physical Tests Miss Key Factors In Chronic Pelvic Pain
Trial Briefs

Physical Tests Miss Key Factors In Chronic Pelvic Pain

Standard physical tests often fail to diagnose chronic pelvic pain effectively. Learn how brain processing and inflammation play a larger...

Scientists find boosting glutathione may slow age-related cellular decline
Vaccine News

Scientists find boosting glutathione may slow age-related cellular decline

Scientists suggest boosting glutathione may slow age-related cellular decline, offering one of the most promising approaches to support long-term health.

Family Doctors’ Approach to Hearing Loss Referrals
Vaccine News

Family Doctors’ Approach to Hearing Loss Referrals

Family physicians weigh multiple factors when deciding whether to refer a patient for a hearing assessment, including symptoms and access...

Tirzepatide and semaglutide have similar asthma risks
Trial Briefs

Tirzepatide and semaglutide have similar asthma risks

Tirzepatide and semaglutide have similar asthma risks in adults with type 2 diabetes and asthma.

FDA Reviews Two Novel ADHD Drug Candidates in Late-Stage Development
Clinic Moves

FDA Reviews Two Novel ADHD Drug Candidates in Late-Stage Development

FDA reviews two novel ADHD drug candidates in late-stage development, offering new approaches to treatment.

Doctors reject federal vaccine changes lacking scientific backing
Drug Approvals

Doctors reject federal vaccine changes lacking scientific backing

Doctors reject federal vaccine changes lacking scientific backing as top medical groups like AAP and ACOG defend evidence-based immunization schedules.

Psychiatrist Shares Strategies for Managing Challenging Patient Relationships
Vaccine News

Psychiatrist Shares Strategies for Managing Challenging Patient Relationships

Effective strategies for managing challenging patient relationships, focusing on cases where patients reject care or question competence.

FIB-4 Index Celebrates 20 Years Guiding Liver Care
Outbreak Watch

FIB-4 Index Celebrates 20 Years Guiding Liver Care

The FIB-4 index celebrates 20 years as a non‑invasive tool for spotting advanced liver fibrosis in MASLD, MASH, hepatitis C...

New ATA guidelines on thyroid disease in pregnancy and preconception
Vaccine News

New ATA guidelines on thyroid disease in pregnancy and preconception

New ATA guidelines for thyroid disease in pregnancy and preconception provide expert updates on testing, hypothyroidism, and iodine intake for...

Noninvasive tests replace biopsies for liver disease diagnosis
Trial Briefs

Noninvasive tests replace biopsies for liver disease diagnosis

Noninvasive tests now replace risky liver biopsies for diagnosing metabolic dysfunction-associated steatohepatitis (MASH) and MASLD, offering safer, cost-effect

Show More →